TrialNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2025

A double-blind, controlled trial of circadian effective light therapy in patients with Parkinson's disease.

Bradley T Wyman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.